Current filters:  
Life Sciences, Biotechnology & Nanotechnology
Smart & Biggar
Health Canada has instituted numerous measures to help address and combat COVID-19, from facilitating access to COVID-19 products to protecting the public from false ...
Smart & Biggar
In view of COVID-19, we have compiled a list of important updates as it relates to the pandemic and its impact on Life Sciences.
Smart & Biggar
We discussed Health Canada's Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors (Notice) in a previous bulletin.
In a split decision (3-2-4) the Supreme Court of Canada (SCC) upheld the Genetic Non-Discrimination Act, a federal law designed to protect personal information and prevent genetic discrimination.
Bereskin & Parr LLP
On June 30, 2020, the United States Patent and Trademark Office (USPTO) revised the Manual of Patent Examining Procedure (MPEP) Ninth Edition and updated it to reflect current USPTO patent...
Stikeman Elliott LLP
À la lumière de l'évolution rapide des soins de santé en réponse à la pandémie de COVID-19, Mario Nigro, associé de nos groupes Fusions et acquisitions et Capital-investissement, a organisé
Smart & Biggar
In the first half of 2020, Rx IP Update reported on a number of developments in Canadian life sciences IP and regulatory law.
Norton Rose Fulbright Canada LLP
In this legal update and in a forthcoming legal update, we will be addressing two proposed regulations published by the Office des professions du Québec.
Human genetic resources (HGR) have long been regulated in China under the Interim Measures for the Administration of HGR (人类遗传资源管理暂行办法) (Interim Measures)...
Arnold & Porter
Multinational pharmaceutical and medical device companies conducting clinical trials in China have been facing new challenges in the year since the Regulation on Human Genetic Resources...
Ropes & Gray LLP
China's State Council released the new Cosmetic Regulation (the "New Regulation") on June 16, 2020, which is a major overhaul of the current 30-year-old Cosmetic Regulation
By Ministerial Agreement No. 00126-2020 of March 11, 2020, the Ministry of Health declared a state of sanitary emergency in Ecuador due to the COVID-19 virus pandemic.
Mediante Acuerdo Ministerial No. 00126-2020 de 11 de marzo de 2020, el Ministerio de Salud declaró el estado de emergencia sanitaria en Ecuador debido a la pandemia del virus COVID-19.
European Union
Arnold & Porter
Commentary on EU life science advertising regulation frequently focuses on the rules applicable to advertisements for prescription products directed to healthcare professionals.
Arnold & Porter
Life sciences companies are doing their best to conduct business through remote customer interactions, and many expect that the expanded use of the technologies that facilitate...
Jones Day
On June 15, 2020, the Japanese government implemented new regulations that designate the manufacture of pharmaceuticals for infectious diseases and the manufacture ...
Ogier's Cayman Islands team has advised ARYA Sciences Acquisition Corp (ARYA), a special purpose acquisition company sponsored by Perceptive Advisors, LLC
Caiado Guerreiro, Sociedade de Advogados
Ordinance No. 90-A/2020, of April 9, has just arrived and it brings about an exceptional and temporary regime for electronic prescription of medicines and respective medical prescriptions...
Caiado Guerreiro, Sociedade de Advogados
Following the declaration by the World Health Organization of a world health emergency due to the infection by SARS-CoV-2, the Portuguese Drug Agency (INFARMED) has published a set of exceptional measures ...
Mondaq Webinars
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Font Size:
Mondaq Social Media